Aspergillus appendicitis in acute myeloid leukaemia.
Rogers
S
S
Department of Haematology, Southmead Hospital, Westbury-on-Trym, Bristol.
Potter
M N
MN
Slade
R R
RR
D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D001064:Appendicitis / Q000188:drug therapy / Q000209:etiology* / Q000601:surgery; D001065:Appendix / Q000098:blood supply; D001228:Aspergillosis / Q000209:etiology*; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D006801:Humans; D007077:Ileal Diseases / Q000209:etiology; D007084:Iliac Vein; D007416:Intestinal Perforation / Q000209:etiology; D007511:Ischemia / Q000209:etiology; D015470:Leukemia, Myeloid, Acute / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008942:Mitoxantrone / Q000008:administration & dosage; D009503:Neutropenia / Q000139:chemically induced / Q000150:complications; D013927:Thrombosis / Q000209:etiology
D003561:Cytarabine; D000666:Amphotericin B; D008942:Mitoxantrone; D003630:Daunorubicin